- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
PE Triage Platform from RapidAI Receives FDA 510(k) Clearance
The new artificial intelligence-powered software reportedly helps detect central pulmonary embolism (PE) on computed tomography pulmonary angiogram (CTPA) images and streamlines communication among interventional teams to bolster treatment outcomes.
Could an emerging artificial intelligence (AI)-enabled triage platform facilitate earlier detection and treatment for people who suffer a pulmonary embolism (PE)?
The Rapid PE Triage & Notification product has garnered 510(k) clearance from the Food and Drug Administration (FDA), according to the product’s manufacturer RapidAI.
The AI-enabled platform reportedly offers a variety of key benefits in the diagnosis and treatment of PE.
• Enhanced identification of suspected central PE on computed tomography pulmonary angiogram (CTPA) images
• Real-time notification with previews of CTPA imaging available for review via mobile devices, desktop computers and laptops
• Streamlined communication among interventional teams to facilitate triage of priority cases and timely treatment
“I’m excited to see firsthand how artificial intelligence will transform the way we triage and manage PE, a historically complicated process involving a diverse care team,” noted Jimmy Kerrigan, MD, FSCAI, FACC, RPVI, an interventional cardiologist affiliated with Ascension Saint Thomas Heart at multiple locations in Tennessee. “After seeing what RapidAI technology has done for stroke, I’m optimistic about about its potential to optimize our care for patients and to hopefully improve patient outcomes.”
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
